» Articles » PMID: 36016331

Isolation and Characterization of the Lytic Phage PW916

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 Aug 26
PMID 36016331
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of multidrug-resistant bacterial pathogens poses a serious global health threat. While patient infections by the opportunistic human pathogen spp. have been increasingly reported worldwide, no phage associated with this bacterial genus has yet been isolated and reported. In this study, we isolated and characterized the novel phage PW916 to subsequently be used to lyse the multidrug-resistant which was isolated from soil samples obtained from Chongqing, China. We studied the morphological features, thermal stability, pH stability, optimal multiplicity of infection, and genomic sequence of phage PW916. Transmission electron microscopy revealed the morphology of PW916 and indicated it to belong to the family, with the morphological characteristics of a rounded head and a long noncontractile tail. The optimal multiplicity of infection of PW916 was 0.1. Moreover, PW916 was found to be stable under a wide range of temperatures (4-60 °C), pH (4-11) as well as treatment with 1% () chloroform. The genome of PW916 was determined to be a circular double-stranded structure with a length of 47,760 bp, containing 64 open reading frames that encoded functional and structural proteins, while no antibiotic resistance nor virulence factor genes were detected. The genomic sequencing and phylogenetic tree analysis showed that PW916 was a novel phage belonging to the family that was closely related to the phage. This is the first study to identify a novel phage infecting the multidrug-resistant and the findings provide insight into the potential application of PW916 in future phage therapies.

Citing Articles

Analysis of a novel phage as a promising biological agent targeting multidrug resistant Klebsiella pneumoniae.

Abdel-Razek M, Nazeih S, Yousef N, Askoura M AMB Express. 2025; 15(1):37.

PMID: 40044971 PMC: 11882492. DOI: 10.1186/s13568-025-01846-0.


Isolation and Characterization of a Lytic Bacteriophage RH-42-1 of from Orchard Soil in China.

Xi H, Fu B, Sheng Q, Luo M, Sun L Viruses. 2024; 16(4).

PMID: 38675852 PMC: 11054837. DOI: 10.3390/v16040509.


Bacterial isolation and genome analysis of a novel Klebsiella quasipneumoniae phage in southwest China's karst area.

Liu Y, Wang J, Zhao R, Liu X, Dong Y, Shi W Virol J. 2024; 21(1):56.

PMID: 38448926 PMC: 10916049. DOI: 10.1186/s12985-024-02321-1.

References
1.
Wiegand I, Hilpert K, Hancock R . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. DOI: 10.1038/nprot.2007.521. View

2.
Djebara S, Maussen C, De Vos D, Merabishvili M, Damanet B, Pang K . Processing Phage Therapy Requests in a Brussels Military Hospital: Lessons Identified. Viruses. 2019; 11(3). PMC: 6466067. DOI: 10.3390/v11030265. View

3.
Sausset R, Petit M, Gaboriau-Routhiau V, De Paepe M . New insights into intestinal phages. Mucosal Immunol. 2020; 13(2):205-215. PMC: 7039812. DOI: 10.1038/s41385-019-0250-5. View

4.
Dahlman S, Avellaneda-Franco L, Barr J . Phages to shape the gut microbiota?. Curr Opin Biotechnol. 2020; 68:89-95. DOI: 10.1016/j.copbio.2020.09.016. View

5.
Wang X, Wei Z, Yang K, Wang J, Jousset A, Xu Y . Phage combination therapies for bacterial wilt disease in tomato. Nat Biotechnol. 2019; 37(12):1513-1520. DOI: 10.1038/s41587-019-0328-3. View